Prognostic role of the stromal tumor-infiltrating lymphocytes (TILs) in women with early ER+/HER2+breast cancer (BC) in whom adjuvant chemotherapy (ChT) was omitted.

被引：0
|
作者：
Horvat, Valentina Jeric
Manevski, Damjan
Gazic, Barbara
Drev, Primoz
Matos, Erika
Ribnikar, Domen
Seruga, Bostjan
机构：
[1] Inst Oncol Ljubljana, Div Med Oncol, Ljubljana, Slovenia
[2] Univ Ljubljana, Inst Biostat & Med Informat, Fac Med, Ljubljana, Slovenia
[3] Inst Oncol Ljubljana, Dept Pathol, Ljubljana, Slovenia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12526
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Dynamics of tumor-infiltrating lymphocytes (TILs) during neoadjuvant dual HER2 blockade in HER2-positive (HER2+) breast cancer in the absence of chemotherapy
    Griguolo, G.
    Holgado, E.
    Cortes, J.
    Fasani, R.
    Pascual, T.
    Pare, L.
    Bermejo, B.
    Oliveira, M.
    Morales, S.
    Martinez, N.
    Vidal, M.
    Pernas, S.
    Lopez, R.
    Munoz, M.
    Galvan, P.
    Garau, I.
    Manso, L.
    Alarcon, J.
    Martinez, E.
    Villagrasa, P.
    LLombart-Cussac, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [32] Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer
    Chaohui Lisa Zhao
    Kamaljeet Singh
    Alexander S. Brodsky
    Shaolei Lu
    Theresa A. Graves
    Mary Anne Fenton
    Dongfang Yang
    Ashlee Sturtevant
    Murray B. Resnick
    Yihong Wang
    BMC Cancer, 19
  • [33] Investigating the role of tumor-infiltrating lymphocytes in advanced HER2-positive breast cancer
    Luen, Stephen J.
    Loi, Sherene
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)
  • [34] Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer
    Zhao, Chaohui Lisa
    Singh, Kamaljeet
    Brodsky, Alexander S.
    Lu, Shaolei
    Graves, Theresa A.
    Fenton, Mary Anne
    Yang, Dongfang
    Sturtevant, Ashlee
    Resnick, Murray B.
    Wang, Yihong
    BMC CANCER, 2019, 19 (01)
  • [35] Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer
    Heppner, B. Ingold
    Untch, M.
    Denkert, C.
    Pfitzner, B. M.
    Lederer, B.
    Schmidt, W.
    Eidtmann, H.
    Fasching, P.
    Tesch, H.
    Solbach, C.
    Rezai, M.
    Zahm, D. -M.
    Holms, F.
    Glados, M.
    Krabisch, P.
    Heck, E.
    Ober, A.
    Lorenz, P.
    Diebold, K.
    Habeck, J.
    Loibl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 5 - 5
  • [36] Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab
    Lee, Hee Jin
    Kim, Joo Young
    Park, In Ah
    Song, In Hye
    Yu, Jong Han
    Ahn, Jin-Hee
    Gong, Gyungyub
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (02) : 278 - 288
  • [37] Adjuvant chemotherapy in stage II and III colon cancer: the role of the "budding and TILs-(tumor-infiltrating lymphocytes) combination" as tumor-host antagonists
    Lang-Schwarz, Corinna
    Melcher, Balint
    Dregelies, Theresa
    Norouzzadeh, Zahra
    Rund-Kuffner, Stefanie
    Lang-Schwarz, Klaus
    Vieth, Michael
    Sterlacci, William
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (08) : 1765 - 1779
  • [38] Prognostic value of tumor-infiltrating lymphocytes (TILs) and clinical values for prediction of breast cancer recurrence in HER2 positive early breast cancer after surgery in King Chulalongkorn Memorial Hospital
    Prapatsornvichit, S.
    Atikankul, T.
    Sriuranpong, V.
    Poovorawan, N.
    Parinyanitikul, N.
    CANCER RESEARCH, 2019, 79 (04)
  • [39] Adjuvant chemotherapy in stage II and III colon cancer: the role of the “budding and TILs-(tumor-infiltrating lymphocytes) combination” as tumor-host antagonists
    Corinna Lang-Schwarz
    Balint Melcher
    Theresa Dregelies
    Zahra Norouzzadeh
    Stefanie Rund-Küffner
    Klaus Lang-Schwarz
    Michael Vieth
    William Sterlacci
    International Journal of Colorectal Disease, 2021, 36 : 1765 - 1779
  • [40] Prognostic value of tumor-infiltrating lymphocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
    Adams, S.
    Gray, R.
    Demaria, S.
    Goldstein, L. J.
    Perez, E. A.
    Shulman, L. N.
    Martino, S.
    Davidson, N. E.
    Sledge, G. W.
    Sparano, J. A.
    Badve, S. S.
    CANCER RESEARCH, 2013, 73
12345